Associated Banc-Corp’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.4M Sell
177,589
-5,375
-3% -$515K 0.41% 69
2025
Q4
$17.6M Sell
182,964
-1,829
-1% -$178K 0.45% 61
2025
Q3
$17.6M Buy
184,793
+5,661
+3% +$520K 0.46% 59
2025
Q2
$15.6M Sell
179,132
-1,050
-0.6% -$89K 0.44% 63
2025
Q1
$16.2M Buy
180,182
+9,244
+5% +$827K 0.49% 57
2024
Q4
$13.7M Sell
170,938
-840
-0.5% -$72.7K 0.41% 67
2024
Q3
$15.5M Buy
171,778
+18,542
+12% +$1.56M 0.45% 63
2024
Q2
$12.1M Sell
153,236
-7,238
-5% -$593K 0.38% 70
2024
Q1
$14M Buy
160,474
+12,766
+9% +$1.09M 0.44% 65
2023
Q4
$12.2M Buy
147,708
+1,093
+0.7% +$83.3K 0.42% 67
2023
Q3
$11.5M Buy
146,615
+30,080
+26% +$2.52M 0.44% 63
2023
Q2
$10.3M Buy
116,535
+14,386
+14% +$1.24M 0.39% 76
2023
Q1
$8.24M Buy
102,149
+10,680
+12% +$870K 0.33% 80
2022
Q4
$7.11M Sell
91,469
-4,995
-5% -$405K 0.3% 89
2022
Q3
$7.79M Buy
96,464
+1,678
+2% +$151K 0.36% 77
2022
Q2
$8.51M Buy
94,786
+17,536
+23% +$1.78M 0.37% 76
2022
Q1
$8.57M Buy
77,250
+12,953
+20% +$1.37M 0.33% 79
2021
Q4
$6.65M Buy
64,297
+19,077
+42% +$2.21M 0.24% 94
2021
Q3
$5.67M Buy
45,220
+33,093
+273% +$4.28M 0.22% 100
2021
Q2
$1.5M Buy
12,127
+3,842
+46% +$482K 0.06% 177
2021
Q1
$747K Sell
8,285
-281
-3% -$32.9K 0.05% 179
2020
Q4
$1M Sell
8,566
-234
-3% -$25.8K 0.04% 212
2020
Q3
$914K Sell
8,800
-37
-0.4% -$3.72K 0.04% 210
2020
Q2
$810K Sell
8,837
-190
-2% -$18.2K 0.04% 217
2020
Q1
$814K Sell
9,027
-555
-6% -$59K 0.04% 206
2019
Q4
$1.09M Buy
9,582
+843
+10% +$92.5K 0.05% 181
2019
Q3
$949K Buy
8,739
+181
+2% +$18.9K 0.05% 185
2019
Q2
$833K Sell
8,558
-100
-1% -$9.13K 0.05% 191
2019
Q1
$789K Sell
8,658
-662
-7% -$59.3K 0.05% 193
2018
Q4
$848K Buy
9,320
+614
+7% +$57.4K 0.06% 185
2018
Q3
$856K Buy
8,706
+71
+0.8% +$6.56K 0.05% 189
2018
Q2
$739K Sell
8,635
-1,003
-10% -$83.8K 0.04% 195
2018
Q1
$773K Sell
9,638
-597
-6% -$49.2K 0.04% 194
2017
Q4
$826K Buy
10,235
+1,031
+11% +$82.6K 0.04% 196
2017
Q3
$716K Sell
9,204
-3,667
-28% -$304K 0.04% 193
2017
Q2
$1.14M Hold
12,871
0.06% 167
2017
Q1
$1.04M Sell
12,871
-200
-2% -$15.6K 0.06% 172
2016
Q4
$931K Sell
13,071
-2,828
-18% -$222K 0.06% 171
2016
Q3
$1.37M Sell
15,899
-235
-1% -$20.5K 0.09% 152
2016
Q2
$1.4M Sell
16,134
-500
-3% -$40.4K 0.09% 150
2016
Q1
$1.25M Sell
16,634
-513
-3% -$38.6K 0.08% 160
2015
Q4
$1.32M Sell
17,147
-4,019
-19% -$303K 0.09% 156
2015
Q3
$1.42M Sell
21,166
-6,088
-22% -$448K 0.1% 153
2015
Q2
$2.02M Sell
27,254
-1,160
-4% -$88.6K 0.13% 138
2015
Q1
$2.22M Buy
28,414
+411
+1% +$31.2K 0.14% 132
2014
Q4
$2.02M Buy
28,003
+958
+4% +$66.5K 0.13% 134
2014
Q3
$1.68M Sell
27,045
-326
-1% -$20.7K 0.11% 145
2014
Q2
$1.75M Buy
27,371
+310
+1% +$18.8K 0.11% 141
2014
Q1
$1.67M Buy
27,061
+3,948
+17% +$230K 0.11% 140
2013
Q4
$1.33M Sell
23,113
-161
-0.7% -$9.13K 0.1% 146
2013
Q3
$1.24M Buy
23,274
+920
+4% +$49.5K 0.1% 142
2013
Q2
$1.15M Buy
+22,354
New +$1.1M 0.09% 143

Other funds holding MDT

Associated Banc-Corp's MDT Position: Q1 2026 in Review

Associated Banc-Corp reduced its Medtronic (MDT) stake by 2.9% in Q1 2026, selling an estimated $515K and leaving 177,589 shares worth $15.4M. The position accounts for 0.41% of the portfolio, ranked #69.

Associated Banc-Corp first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.6M in Q3 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Associated Banc-Corp held 177,589 shares of Medtronic worth $15.4M as of Q1 2026.
  • Associated Banc-Corp sold 5,375 Medtronic shares in Q1 2026, an estimated $515K.
  • Medtronic made up 0.41% of Associated Banc-Corp's portfolio in Q1 2026, its #69 holding.
  • Associated Banc-Corp first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Associated Banc-Corp's Medtronic position peaked at $17.6M in Q3 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Associated Banc-Corp's 13F filing for Q1 2026, filed 1 May 2026.